RetiSpec was an early stage medical device startup developing a non-invasive eye scanner for early detection of Alzheimer’s Disease. The company was selected as the finalists at the MassChallenge Boston accelerator & had won 1st place at the JNF Lions-Den competition in Toronto & at the 2016 Partners Connected Health and AARP startup competition in Boston. As of Jan 2017, the company hasn't disclosed its product development details. Founded in 2015, headquartered in Tel Aviv, Israel. The company operates in the Eye Tracking sector with additional focus on Healthcare IT. Its business model centers on Healthcare. Founded in 2015, headquartered in Tel Aviv, Israel. The company has raised $17.0M at the Series A stage. Backed by investors including Ontario Brain Institute, Alzheimer's Drug Discovery, iGan Partners, Lilly, Topconhealthcare and others.
RetiSpec
Series ARetiSpec was an early stage medical device startup developing a non-invasive eye scanner for early detection of Alzheimer’s Disease. The company was selected as the finalists at the MassChallenge Boston accelerator & had won 1st place at the JNF Lions-Den competition in Toronto & at the 2016 Partners Connected Health and AARP startup competition in Boston. As of Jan 2017, the company hasn't disclosed its product…
About
Business model
Eye Tracking > Applications > Healthcare,
Healthcare IT > Provider > Clinical Operations > Decision Support > Diagnosis > Differential Diagnosis > Diagnostics > Devices and platform > Neurology,
MassChallenge Batches > Boston > 2016
Institutional investors
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Backed by funds in our directory
🗂️ See who's investing in High Tech — full fund directory with check size and geography.